Molecular and cellular mechanisms of liver fibrosis and its regression

T Kisseleva, D Brenner - Nature Reviews Gastroenterology & …, 2021 - nature.com
Chronic liver injury leads to liver inflammation and fibrosis, through which activated
myofibroblasts in the liver secrete extracellular matrix proteins that generate the fibrous scar …

[HTML][HTML] Crosstalk between oxidative stress and inflammatory liver injury in the pathogenesis of alcoholic liver disease

YM Yang, YE Cho, S Hwang - International journal of molecular sciences, 2022 - mdpi.com
Alcoholic liver disease (ALD) is characterized by the injury, inflammation, and scarring in the
liver owing to excessive alcohol consumption. Currently, ALD is a leading cause for liver …

Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting

MA Avila, JF Dufour, AL Gerbes, F Zoulim, R Bataller… - Gut, 2020 - gut.bmj.com
Alcohol-related liver disease (ALD), which includes a range of disorders of different severity
and is one of the most prevalent types of liver disease worldwide, has recently regained …

[HTML][HTML] Pathogenesis of alcoholic liver disease: role of oxidative metabolism

E Ceni, T Mello, A Galli - World Journal of Gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Alcohol consumption is a predominant etiological factor in the pathogenesis of chronic liver
diseases, resulting in fatty liver, alcoholic hepatitis, fibrosis/cirrhosis, and hepatocellular …

Alcoholic liver disease

HK Seitz, R Bataller, H Cortez-Pinto, B Gao… - Nature reviews Disease …, 2018 - nature.com
Alcoholic liver disease (ALD) is the most prevalent type of chronic liver disease worldwide.
ALD can progress from alcoholic fatty liver (AFL) to alcoholic steatohepatitis (ASH), which is …

[HTML][HTML] Fibrosis related inflammatory mediators: role of the IL-10 cytokine family

E Sziksz, D Pap, R Lippai, NJ Béres, A Fekete… - Mediators of …, 2015 - hindawi.com
Importance of chronic fibroproliferative diseases (FDs) including pulmonary fibrosis, chronic
kidney diseases, inflammatory bowel disease, and cardiovascular or liver fibrosis is rapidly …

An open‐label, dose‐escalation study to assess the safety and efficacy of IL‐22 agonist F‐652 in patients with alcohol‐associated hepatitis

JP Arab, TS Sehrawat, DA Simonetto, VK Verma… - …, 2020 - Wiley Online Library
Background and Aims Interleukin‐22 has beneficial effects on inflammation and impaired
hepatic regeneration that characterize alcohol‐associated hepatitis (AH). F‐652 is a …

Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis

K Baghaei, S Mazhari, S Tokhanbigli… - Drug discovery today, 2022 - Elsevier
Highlights•Hepatic stellate cell activation/myofibroblast transition is the main driver of liver
fibrosis.•Paracrine signals from adjacent cells induce stellate cell activation.•Alteration in …

[HTML][HTML] Role of neutrophils in the pathogenesis of nonalcoholic steatohepatitis

S Hwang, H Yun, S Moon, YE Cho… - Frontiers in endocrinology, 2021 - frontiersin.org
Nonalcoholic fatty liver disease (NAFLD) includes a spectrum of liver disorders, from fatty
liver to nonalcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma …

Linking pathogenic mechanisms of alcoholic liver disease with clinical phenotypes

LE Nagy, WX Ding, G Cresci, P Saikia, VH Shah - Gastroenterology, 2016 - Elsevier
Alcoholic liver disease (ALD) develops in approximately 20% of alcoholic patients, with a
higher prevalence in females. ALD progression is marked by fatty liver and hepatocyte …